Cargando…
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Autores principales: | Zhang, Haikuo, Brainson, Christine Fillmore, Koyama, Shohei, Redig, Amanda J., Chen, Ting, Li, Shuai, Gupta, Manav, Garcia-de-Alba, Carolina, Paschini, Margherita, Herter-Sprie, Grit S., Lu, Gang, Zhang, Xin, Marsh, Bryan P, Tuminello, Stephanie J., Xu, Chunxiao, Chen, Zhao, Wang, Xiaoen, Akbay, Esra A., Zheng, Mei, Palakurthi, Sangeetha, Sholl, Lynette M., Rustgi, Anil K., Kwiatkowski, David J., Alan Diehl, J., Bass, Adam J., Sharpless, Norman E., Dranoff, Glenn, Hammerman, Peter S., Ji, Hongbin, Bardeesy, Nabeel, Saur, Dieter, Watanabe, Hideo, Kim, Carla F., Wong, Kwok-Kin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472705/ https://www.ncbi.nlm.nih.gov/pubmed/28598439 http://dx.doi.org/10.1038/ncomms15901 |
Ejemplares similares
-
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
por: Zhang, Haikuo, et al.
Publicado: (2017) -
Somatic LKB1 Mutations Promote Cervical Cancer Progression
por: Wingo, Shana N., et al.
Publicado: (2009) -
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
por: Koyama, Shohei, et al.
Publicado: (2016) -
Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
por: Herter-Sprie, Grit S., et al.
Publicado: (2013) -
The LKB1 Tumor Suppressor as a Biomarker in Mouse and Human Tissues
por: Nakada, Yuji, et al.
Publicado: (2013)